MEDICINE TYPE |
Primary and Secondary Care |
Further action in Secondary Care |
Anticholinergics: These include antidepressants, overactive bladder meds, antihistamines, anti-emetics. |
|
|
Analgesics |
|
|
Atypical Analgesics: Eg: amitriptyline, duloxetine, gabapentin, pregabalin. |
|
|
Antibiotics Eg: gentamicin. |
|
|
Anticoagulants |
|
|
Anticonvulsants |
|
|
Antidepressants |
|
|
Antipsychotics |
|
|
Benzodiazepines and Z drugs. |
|
|
Bladder medicines Eg: tamsulosin, solifenacin, tolterodine. |
|
|
Blood pressure lowering drugs Eg: ACE Inhibitors, alpha blockers, diuretics. |
|
|
Eye treatments |
|
|
Hypoglycaemics |
|
|
Muscle relaxants Eg: baclofen. |
|
|
Parkinsonian medicine |
|
|
Post-fall medication review (Guidelines)
What's new / Latest updates
25/11/24:
- Content refined. Changes include:
- From: 'Consider GI protection' to: 'Avoid NSAIDs in older adults'.
- Anticonvulsants and Antidepressants: 'Ensure correct preparation has been prescribed, eg, modified release' added.
- Antidepressants: 'do not stop abruptly' added.
- BP lowering: From: 'review' To: 'withhold if AKI'.
Audience
- All NHSH
- Primary and Secondary care, including Care Homes and Community Hospital settings
- Adults only
The following medicines can contribute to falls in older patients and should be reviewed. This list is NOT exhaustive.
For in-patients, if there are ongoing concerns, discuss with the senior medical team.
The greater the number of medicines a patient takes, the greater their risk of sustaining a fall, especially if these medicines affect the central nervous or cardiovascular system.
When reviewing medicines consider:
- Is there any NEW medication or recent change in dosage?
- Consider the level of compliance pre-admission.
- See Scottish Polypharmacy guidance and consider Realistic Medicine. What matters to the patient?
- ACB: Anticholinergic burden
- AKI: Acute kidney injury
- BM: Blood sugar level
- BP: Blood pressure
- D&V: diarrhoea and vomiting
- HbA1c: Glycated haemoglobin
- Mental Health Liaison Team
- NSAID: non-steroidal anti-inflammatory drug
- PE: Pulmonary embolism